Possible options for the Vitacoin project’s future (calculation of estimated capitalization*)

Optimistic scenario of project development depending on the number of users

By increasing the number of active users, the project capitalization can reach approximately $ 1 trillion (with 5 billion active users).

Based on the financial parameters of social networks (for example, Facebook), such as revenue ($ 40.6 billion for 2017), capitalization ($ 408 billion), and the number of active users in the amount of 2.2 billion, we can calculate that about $ 200 per month are the contribution of one user to the capitalization of Facebook. Extrapolating these values linearly in both directions, we get a graph of dependence of capitalization on the users of the site (in million people, lower axis), who visit the site at least once a month.

If our calculations are correct, then with 5 billion active users, the project’s capitalization can reach approximately $ 1 trillion through advertising and services sold.

Optimistic scenario of project development depending on Healthcare market assumption

The capitalization of the global Healthcare market in 2017 is estimated at about $ 46.7 trillion. This amount was obtained by averaging the revenue and profit of different companies, as well as data from the World Bank and Fidelity. Presumably, the capitalization of this sector will increase at an average annual growth rate of 10% (based on average inflation rates during periods of soft monetary policy, as well as average growth in Healthcare capitalization). This means that under the condition of maintaining such rates by 2079, it can reach $ 17,205 trillion (or $ 17.2 quadrillion).

If we assume that in 62 years there will be a technology or therapy that will offset all the effects of aging and replace the existing treatment, the estimated capitalization of the project can be calculated through the percentage of the total market that Vitacoin replaces with its technologies..

The share increases linearly by 2% every year after 12 years of development (starting in 2030) and appearance of the first significant results available to everyone on the market.

As a result, by 2080, Vitacoin will occupy up to 90% of the Heathcare market and its capitalization will reach $ 17,205 trillion.

The anti-aging agent developed as a result of the project implementation will effectively fight most diseases and will eventually replace most existing drugs. Thus, the capitalization of the Vitacoin project may amount to 10% of global GDP.

Optimistic scenario of project development depending on total amount of received revenue

You need to understand the full scale of this project and its duration. We estimate the total amount of funds needed for Vitacoin development at $ 10 trillion with a project implementation period of 20 to 60 years. This assessment is based on the ongoing costs of research and development by leading pharmaceutical corporations, despite the fact that their goals are specific, highly specialized drugs.

We will suspend Vitacoin as soon as we manage to create and market the appropriate drug or technology.

Pessimistic scenario of project development in the case of objective impossibility to create a medicine or technology capable of significantly prolonging life

For reasons beyond our control, the declared drug or technology may not be created, even with all the effort involved. Therefore, it may happen that all the money spent does not bring the desired result. But even in this case, we are confident that we will make a significant contribution to the development of humankind. We will approximate the moment of a radical life prolongation.

Pessimistic scenario of project development in connection with creation of the required drug or technology later than the terms indicated in the roadmap

In addition, one cannot rule out possibility that the stated maximum project implementation period of 60 years may not be sufficient for a significant leap in the development of scientific progress needed to achieve this goal. Therefore, it is possible that a medicine or technology capable of significantly prolonging a person’s life will be created, for example, in 100-300 years, and we will not be able to use it. However, even in this case, we will create a foundation for future generations.